{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:23:17Z","timestamp":1793157797658,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Great Lakes Regional Center of Excellence","award":["U54 AI057153"],"award-info":[{"award-number":["U54 AI057153"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.07.134","type":"journal-article","created":{"date-parts":[[2011,8,13]],"date-time":"2011-08-13T21:15:57Z","timestamp":1313270157000},"page":"7688-7695","source":"Crossref","is-referenced-by-count":13,"title":["Subunit vaccine efficacy against Botulinum neurotoxin subtypes"],"prefix":"10.1016","volume":"29","author":[{"given":"James S.","family":"Henkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Tepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Przedpelski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"March (1)","key":"10.1016\/j.vaccine.2011.07.134_bib0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/MMBR.46.1.86-94.1982","article-title":"Bacterial toxins: a table of lethal amounts","volume":"46","author":"Gill","year":"1982","journal-title":"Microbiol Rev"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2011.07.134_bib0010","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1006\/jmbi.1999.2945","article-title":"Sequence homology and structural analysis of the clostridial neurotoxins","volume":"291","author":"Lacy","year":"1999","journal-title":"J Mol Biol"},{"issue":"September\u2013October (9\u201310)","key":"10.1016\/j.vaccine.2011.07.134_bib0015","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0300-9084(00)01173-1","article-title":"Development of vaccines for prevention of botulism","volume":"82","author":"Byrne","year":"2000","journal-title":"Biochimie"},{"issue":"September (4)","key":"10.1016\/j.vaccine.2011.07.134_bib0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jmb.2006.07.040","article-title":"A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1\u2013A4","volume":"362","author":"Arndt","year":"2006","journal-title":"J Mol Biol"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2011.07.134_bib0025","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1212\/01.wnl.0000311390.87642.d8","article-title":"Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American academy of neurology","volume":"70","author":"Naumann","year":"2008","journal-title":"Neurology"},{"issue":"January (Database issue)","key":"10.1016\/j.vaccine.2011.07.134_bib0290","first-page":"D408","article-title":"Pathema: a clade-specific bioinformatics resource center for pathogen research","volume":"38","author":"Brinkac","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"September (7)","key":"10.1016\/j.vaccine.2011.07.134_bib0035","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0923-2508(93)90004-L","article-title":"Sequence of the gene coding for the neurotoxin of Clostridium botulinum type A associated with infant botulism: comparison with other clostridial neurotoxins","volume":"144","author":"Willems","year":"1993","journal-title":"Res Microbiol"},{"issue":"June (1)","key":"10.1016\/j.vaccine.2011.07.134_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1574-6968.2004.tb09561.x","article-title":"Nucleotide sequence and transcriptional analysis of the type A2 neurotoxin gene cluster in Clostridium botulinum","volume":"235","author":"Dineen","year":"2004","journal-title":"FEMS Microbiol Lett"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.07.134_bib0295","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AEM.01882-09","article-title":"Expression of the Clostridium botulinum A2 neurotoxin gene cluster proteins and characterization of the A2 complex","volume":"76","author":"Lin","year":"2010","journal-title":"Appl Environ Microbiol"},{"issue":"March (11)","key":"10.1016\/j.vaccine.2011.07.134_bib0050","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1021\/bi801686b","article-title":"Catalytic properties of botulinum neurotoxin subtypes A3 and A4 (dagger)","volume":"48","author":"Henkel","year":"2009","journal-title":"Biochemistry"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.07.134_bib0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.febslet.2010.11.045","article-title":"Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1","volume":"585","author":"Pier","year":"2011","journal-title":"FEBS Lett"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.07.134_bib0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.toxicon.2010.10.009","article-title":"Comparison of effects of botulinum toxin subtype A1 and A2 using twitch tension assay and rat grip strength test","volume":"57","author":"Torii","year":"2011","journal-title":"Toxicon"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.07.134_bib0065","first-page":"85","article-title":"Case of infant botulism in Texas","volume":"73","author":"Edmond","year":"1977","journal-title":"Tex Med"},{"key":"10.1016\/j.vaccine.2011.07.134_bib0070","series-title":"Report to the Scottish board of health","author":"Leighton","year":"1923"},{"issue":"4","key":"10.1016\/j.vaccine.2011.07.134_bib0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1615\/CritRevImmunol.v27.i4.20","article-title":"Botulinum neurotoxin vaccines: past, present, and future","volume":"27","author":"Smith","year":"2007","journal-title":"Crit Rev Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.07.134_bib0080","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1128\/JCM.00799-09","article-title":"Novel Clostridium botulinum toxin gene arrangement with subtype A5 and partial subtype B3 botulinum neurotoxin genes","volume":"47","author":"Dover","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.07.134_bib0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2164-10-115","article-title":"Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum","volume":"10","author":"Carter","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.vaccine.2011.07.134_bib0090","article-title":"Purification, modeling and analysis of neurotoxin BoNT\/A5 from Clostridium botulinum strain A661222","volume":"April","author":"Jacobson","year":"2011","journal-title":"Appl Environ Microbiol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.07.134_bib0095","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0968-0004(86)90282-3","article-title":"How do tetanus and botulinum toxins bind to neuronal membranes?","volume":"11","author":"Montecucco","year":"1986","journal-title":"Trends Biochem Sci"},{"issue":"8","key":"10.1016\/j.vaccine.2011.07.134_bib0100","doi-asserted-by":"crossref","first-page":"e1000129","DOI":"10.1371\/journal.ppat.1000129","article-title":"Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin\u2013neuron interaction","volume":"4","author":"Stenmark","year":"2008","journal-title":"PLoS Pathog"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2011.07.134_bib0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0014-5793(95)01471-3","article-title":"The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b\/GD1a","volume":"378","author":"Nishiki","year":"1996","journal-title":"FEBS Lett"},{"issue":"September (7)","key":"10.1016\/j.vaccine.2011.07.134_bib0110","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1083\/jcb.200305098","article-title":"Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells","volume":"162","author":"Dong","year":"2003","journal-title":"J Cell Biol"},{"issue":"April (5773)","key":"10.1016\/j.vaccine.2011.07.134_bib0115","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.07.134_bib0120","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1091\/mbc.E08-07-0765","article-title":"Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons","volume":"19","author":"Dong","year":"2008","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.vaccine.2011.07.134_bib0125","article-title":"Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F","volume":"May","author":"Fu","year":"2009","journal-title":"Biochemistry"},{"issue":"March (Suppl. 8)","key":"10.1016\/j.vaccine.2011.07.134_bib0130","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1002\/mds.20009","article-title":"Roads from vaccines to therapies","volume":"19","author":"Smith","year":"2004","journal-title":"Mov Disord"},{"issue":"May","key":"10.1016\/j.vaccine.2011.07.134_bib0135","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4049\/jimmunol.90.5.697","article-title":"Studies on immunity to toxins of Clostridium botulinum. Ix. Immunologic response of man to purified pentavalent abcde botulinum toxiod","volume":"90","author":"Fiock","year":"1963","journal-title":"J Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.07.134_bib0140","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/IAI.63.7.2738-2742.1995","article-title":"Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli","volume":"63","author":"Clayton","year":"1995","journal-title":"Infect Immun"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.07.134_bib0145","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","article-title":"Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate","volume":"66","author":"Byrne","year":"1998","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.07.134_bib0150","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1128\/IAI.01025-07","article-title":"Subunit vaccine against the seven serotypes of botulism","volume":"76","author":"Baldwin","year":"2008","journal-title":"Infect Immun"},{"issue":"August (1\u20133)","key":"10.1016\/j.vaccine.2011.07.134_bib0155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.febslet.2004.06.094","article-title":"Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies","volume":"572","author":"Tavallaie","year":"2004","journal-title":"FEBS Lett"},{"issue":"November (Suppl. 4)","key":"10.1016\/j.vaccine.2011.07.134_bib0160","doi-asserted-by":"crossref","first-page":"D33","DOI":"10.1016\/j.vaccine.2009.08.059","article-title":"Botulism and vaccines for its prevention","volume":"27","author":"Smith","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.07.134_bib0165","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1615\/CritRevImmunol.v30.i2.50","article-title":"Mode of action of botulinum neurotoxins: current vaccination strategies and molecular immune recognition","volume":"30","author":"Aoki","year":"2010","journal-title":"Crit Rev Immunol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.07.134_bib0170","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1128\/IAI.73.10.6998-7005.2005","article-title":"Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E","volume":"73","author":"Baldwin","year":"2005","journal-title":"Infect Immun"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.07.134_bib0175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pep.2010.09.016","article-title":"Purification of a recombinant heavy chain fragment C vaccine candidate against botulinum serotype C neurotoxin [rBoNTC(H(c))] expressed in Pichia pastoris","volume":"75","author":"Dux","year":"2011","journal-title":"Protein Expres Purif"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.07.134_bib0180","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1128\/CVI.00496-09","article-title":"Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system","volume":"17","author":"Zichel","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.07.134_bib0185","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1128\/IAI.01893-06","article-title":"Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route","volume":"75","author":"Ravichandran","year":"2007","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2011.07.134_bib0190","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1348-0421.2007.tb03919.x","article-title":"C terminal half fragment (50kDa) of heavy chain components of Clostridium botulinum type C and D neurotoxins can be used as an effective vaccine","volume":"51","author":"Lee","year":"2007","journal-title":"Microbiol Immunol"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2011.07.134_bib0195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1586\/14760584.3.4.477","article-title":"Progress toward development of an inhalation vaccine against botulinum toxin","volume":"3","author":"Park","year":"2004","journal-title":"Expert Rev Vaccines"},{"issue":"May (18)","key":"10.1016\/j.vaccine.2011.07.134_bib0200","doi-asserted-by":"crossref","first-page":"10566","DOI":"10.1074\/jbc.270.18.10566","article-title":"Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins","volume":"270","author":"Schiavo","year":"1995","journal-title":"J Biol Chem"},{"issue":"July (33)","key":"10.1016\/j.vaccine.2011.07.134_bib0205","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2009.05.030","article-title":"Production of catalytically inactive BoNT\/A1 holoprotein and comparison with BoNT\/A1 subunit vaccines against toxin subtypes A1, A2, and A3","volume":"27","author":"Webb","year":"2009","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.07.134_bib0210","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/IAI.00843-07","article-title":"Recombinant holotoxoid vaccine against botulism","volume":"76","author":"Pier","year":"2008","journal-title":"Infect Immun"},{"issue":"January\u2013February (1)","key":"10.1016\/j.vaccine.2011.07.134_bib0215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF02255918","article-title":"DNA vaccination using the fragment C of botulinum neurotoxin type A provided protective immunity in mice","volume":"7","author":"Shyu","year":"2000","journal-title":"J Biomed Sci"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2011.07.134_bib0220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/08923971003782327","article-title":"Enhancement of the immunogenicity of DNA replicon vaccine of Clostridium botulinum neurotoxin serotype A by GM-CSF gene adjuvant","volume":"33","author":"Li","year":"2011","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"May (21)","key":"10.1016\/j.vaccine.2011.07.134_bib0225","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1016\/j.vaccine.2007.02.081","article-title":"Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins","volume":"25","author":"Webb","year":"2007","journal-title":"Vaccine"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.07.134_bib0230","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1083\/jcb.96.5.1374","article-title":"Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation","volume":"96","author":"Huttner","year":"1983","journal-title":"J Cell Biol"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.07.134_bib0235","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/JB.01180-06","article-title":"Genetic diversity among botulinum neurotoxin-producing clostridial strains","volume":"189","author":"Hill","year":"2007","journal-title":"J Bacteriol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.07.134_bib0240","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0041-0101(89)90097-4","article-title":"Gangliosides mediate inhibitory effects of tetanus and botulinum A neurotoxins on exocytosis in chromaffin cells","volume":"27","author":"Marxen","year":"1989","journal-title":"Toxicon"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.07.134_bib0245","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2958.2003.03872.x","article-title":"The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction","volume":"51","author":"Rummel","year":"2004","journal-title":"Mol Microbiol"},{"issue":"February (5)","key":"10.1016\/j.vaccine.2011.07.134_bib0250","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.molimm.2006.03.011","article-title":"Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT\/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT\/A","volume":"44","author":"Dolimbek","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2011.07.134_bib0255","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1128\/IAI.73.9.5358-5366.2005","article-title":"Persistence of zinc-binding bacterial superantigens at the surface of antigen-presenting cells contributes to the extreme potency of these superantigens as T-cell activators","volume":"73","author":"Pless","year":"2005","journal-title":"Infect Immun"},{"issue":"November (16)","key":"10.1016\/j.vaccine.2011.07.134_bib0260","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/S0264-410X(96)00094-1","article-title":"Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum","volume":"14","author":"Dertzbaugh","year":"1996","journal-title":"Vaccine"},{"issue":"November (3\u20134)","key":"10.1016\/j.vaccine.2011.07.134_bib0265","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0264-410X(01)00356-5","article-title":"Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland","volume":"20","author":"Gzyl","year":"2001","journal-title":"Vaccine"},{"issue":"June (17\u201318)","key":"10.1016\/j.vaccine.2011.07.134_bib0270","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.vaccine.2003.12.006","volume":"22","author":"Gzyl","year":"2004","journal-title":"Vaccine"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2011.07.134_bib0275","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.mimet.2005.07.002","article-title":"Comparison of real-time PCR and pyrosequencing for typing Bordetella pertussis toxin subunit 1 variants","volume":"65","author":"Storm","year":"2006","journal-title":"J Microbiol Methods"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.07.134_bib0280","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.anaerobe.2004.01.001","article-title":"Organization and regulation of the neurotoxin genes in Clostridium botulinum and Clostridium tetani","volume":"10","author":"Raffestin","year":"2004","journal-title":"Anaerobe"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2011.07.134_bib0285","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbrc.2007.06.166","article-title":"Plasmid encoded neurotoxin genes in Clostridium botulinum serotype A subtypes","volume":"361","author":"Marshall","year":"2007","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11012035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11012035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T22:41:56Z","timestamp":1712702516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11012035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":57,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11012035"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.134","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}